Word from the C-suite: 'We must continue to innovate' amid potential changes to US healthcare

Johnson & Johnson's CEO said he believes pharmaceutical, medical technology and healthcare companies should continue to emphasize innovation amid challenges that may arise from potential changes to the ACA.

In an interview with Med Device Online, Alex Gorsky, chairman and CEO of Johnson & Johnson, said legislators must continue to make a concerted effort to support companies developing healthcare products intended to help average Americans live healthier lives.

"I think what's important is to make sure obviously that we continue to innovate, that we bring out products that can cure Alzheimer, that can cure cancer, that we price responsibly, that we work on some of the reimbursement mechanisms be it Medicare, be it Medicaid or through private insurance. And I think [there are] ways to do that that can help contain overall costs, make sure that we continue to have an innovative environment that can take on new diseases and be part frankly of a reform of the entire healthcare system."

Click here to view the full article.

If you would like to contribute a quote for this series, please email Alyssa Rege at arege@beckershealthcare.com to be featured in "Word from the C-suite."

More articles on leadership:
Word from the C-suite: 'Health must go beyond health coverage'
Dr. Anthony Tersigni: Collaboration and value are keys to reimagining care
House Freedom Caucus won't take official position on AHCA vote

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers